Results 161 to 170 of about 2,043,354 (309)

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali   +4 more
wiley   +1 more source

Extensively Targeted Metabolomics Analysis of Red and Yellow Wolfberries

open access: yesShipin gongye ke-ji
In the pursuit of a comprehensive understanding of differential metabolites and metabolic pathways between red wolfberry (Lycium barbarum L.) and yellow wolfberry (Lycium barbarum L. var. auranticarpum K.F.Ching), an analytical approach integrating ultra-
Tian LAN   +5 more
doaj   +1 more source

Differentiation of Therapeutic and Illicit Drug Use via Metabolite Profiling

open access: yesMetabolites
Objectives: The therapeutic use of controlled substances, particularly opioids, stimulants, and benzodiazepines, has significantly increased in recent decades. This is often accompanied by non-medical use and diversion, posing challenges for healthcare professionals and forensic experts monitoring potential misuse.
Stanila Stoeva-Grigorova   +5 more
openaire   +2 more sources

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks   +8 more
wiley   +1 more source

Effect of Oat Hay as a Substitute for Alfalfa Hay on the Gut Microbiome and Metabolites of Yak Calves

open access: yesAnimals
To evaluate the impact of different roughages on the intestinal microbiota of yak calves, we fed them oat hay in substitution of alfalfa hay, in addition to milk replacer and starter powder.
Yingchao Gu   +7 more
doaj   +1 more source

Plant Cell and Tissue Differentiation and Secondary Metabolites

open access: yes, 2021
Ramawat, Kishan Gopal   +2 more
openaire   +2 more sources

Juvenile Huntington Disease With Cerebellar‐Predominant Atrophy Identified by Genome Sequencing

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Juvenile Huntington disease accounts for a small fraction of Huntington disease cases and is driven by the largest trinucleotide repeat expansions. We describe a 6‐year‐old boy with progressive global regression, generalized dystonia, and epilepsy, in whom serial imaging showed striking cerebellar‐predominant atrophy with an initially normal ...
Enrique Gonzalez Saez‐Diez   +5 more
wiley   +1 more source

Untargeted plasma metabolite detection in sudden sensorineural hearing loss: identifying key metabolic signatures

open access: yesFrontiers in Molecular Biosciences
BackgroundSudden sensorineural hearing loss (SSNHL) is a common otological disorder with complex etiologies and unclear pathophysiology. This study aimed to detect and analyze plasma metabolites in SSNHL, identify potential biomarkers, and uncover ...
Rongyue Ma   +10 more
doaj   +1 more source

The differential metabolites in liver between C3H-FB and C3H control mice.

open access: yes, 2016
The differential metabolites in liver between C3H-FB and C3H control mice.
Guobing Zhong (3178971)   +5 more
core   +1 more source

Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy